Looking to partner for targeted alpha therapy development?
Our locations
Sydney
Level 7, Macquarie House, 167 Macquarie Street, Sydney, NSW, 2000, Australia
Newcastle
Lab 186, ATC Building Callaghan Campus, University of Newcastle, University Drive, Callaghan NSW 2308 Australia
Brisbane
Y-Block, Queensland Centre for Advanced Technologies (QCAT), 1 Technology Court, Pullenvale, QLD 4069, Australia
Adelaide
B78 Prescott Laboratories, The Braggs Building, The University of Adelaide, Adelaide, SA, 5005
Get in touch
Partnership Programs
AdvanCell operates a comprehensive partnership program for taking novel radioligand therapies from the lab through to Phase 1 and beyond.
cGMP Isotope
AdvanCell provides its cGMP isotope to partners removing reliance on external supply chains.
CMC
AdvanCell’s in-house manufacturing team and infrastructure ensures CMC development to meet FDA requirements.
Clinical Trials
AdvanCell has deep experience in running clinical trials for radioligand therapies.
Australian Advantage
Australia’s world-leading Nuclear Medicine expertise and infrastructure offers a smooth and competitive path for clinical development.